Jul 10, 2024 8:00 AM EDT Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
Jul 2, 2024 4:00 PM EDT Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
Jun 20, 2024 9:15 AM EDT Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
May 13, 2024 8:00 AM EDT TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
May 9, 2024 4:05 PM EDT Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
Apr 30, 2024 7:31 AM EDT TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
Apr 18, 2024 7:36 AM EDT TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
Apr 10, 2024 4:05 PM EDT Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
Mar 18, 2024 9:00 AM EDT Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start